Medera and Cardiovascular Disease National Collaborative Enterprise (CADENCE) announce the initiation of Asia's first cardiac gene therapy clinical trial for heart failure, with Singapore being the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback